Aug 7 (Reuters) - Isis Pharmaceuticals Inc reported a narrower-than-expected quarterly loss, helped by a significant rise in revenue from its corporate partnerships and a decrease in its loss from operations.
Aug 7 (Reuters) - Isis Pharmaceuticals Inc reported a narrower-than-expected quarterly loss, helped by a significant rise in revenue from its corporate partnerships and a decrease in its loss from operations.
